Sofya K. Andrianova

Ms. Sofya K. Andrianova

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
ABAlexander Balatskiy
Alexander Balatskiy
ANAlexey Nesterenko
Alexey Nesterenko
VOVera S. Ovechkina
Vera S. Ovechkina
ALAleksandr A. Lanin
Aleksandr A. Lanin
DJDavid Jappy
David Jappy
VBVsevolod Belousov
Vsevolod Belousov
Cardiac arrhythmias are common disorders that can be fatal. Modern methods of treating bradyarrhythmias include the implantation of pacemakers and cardioverter–defibrillators. However, implantable devices can cause various complications related to the electrodes installed inside the heart, including infection. Less invasive heart rhythm modulation could be beneficial for some cohorts of patients. Here, we demonstrate an alternative approach to heart pacing based on thermogenetics. We used adeno-associated viruses to deliver genetic human transient receptor potential subfamily V member 1 (TRPV1), a heat-sensitive cation channel, into isolated cardiomyocytes and the mouse heart. This allowed us to induce action potentials and control contractility using short heat pulses delivered by infrared laser illumination. Using this approach, we demonstrated the thermogenetic pacing of isolated cardiomyocytes in vitro and in the mouse heart in vivo . Our results demonstrate the potential of thermogenetics for developing therapeutic strategies for heart rhythm modulation.

2 February 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
MBMikhail Blagonravov
Mikhail Blagonravov
ASAnastasia Sklifasovskaya
Anastasia Sklifasovskaya
RKRuslan Karpov
Ruslan Karpov
VOVera Ovechkina
Vera Ovechkina
SASofya K. Andrianova
Sofya K. Andrianova
Andrey MozhaevAndrey Mozhaev
Andrey Mozhaev
Mitochondria serve as an essential component in the maintenance of cardiac function, and targeting them may represent a promising approach to handling heart failure (HF). HF in this review refers to various etiologies, including ischemic cardiomyopathy, dilated cardiomyopathy, and hypertrophic cardiomyopathy, unless otherwise specified. Mitochondrial dysfunction, a distinctive feature of HF, leads to a progressive decrease in bioenergetic reserves due to switching of energy production from oxidation of fatty acids in mitochondria to glycolytic pathways. The main problem in developing methods to improve mitochondrial function lies in the fact that protein preparations injected through the bloodstream cannot enter cells through the plasma membrane. Modern gene therapy involving the delivery of missing genes to cells using adeno-associated virus (AAV) vectors has the potential to improve the function of cardiomyocytes (CMCs). This type of therapy aims to target proteins that have been lost, damaged, or altered due to pathological conditions in the myocardium. This review summarizes pathophysiological mechanisms associated with mitochondrial dysfunction, which is mainly caused by increased oxidative stress and impaired mitochondrial biodynamics under HF progression. It also addresses possible ways to modulate these processes using gene therapy. Special attention is paid to modern characteristics of AAVs that can be used as vectors for the efficient delivery of desired genes to CMCs.

24 October 2026 in Journal of Physiology and Biochemistry
Verified
Journal Article
Closed access
PDF file
ASAnastasia Sklifasovskaya
Anastasia Sklifasovskaya
MBMikhail Blagonravov
Mikhail Blagonravov
MAMadina Azova
Madina Azova
RKRuslan Karpov
Ruslan Karpov
VOVera Ovechkina
Vera Ovechkina
Andrey MozhaevAndrey Mozhaev
Andrey Mozhaev